PUBLISHER: Allied Market Research | PRODUCT CODE: 1472372
PUBLISHER: Allied Market Research | PRODUCT CODE: 1472372
Inhalation Capsules Market By Type (Gelatin Capsules, Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global inhalation capsule market is anticipated to reach $1,464.9 million by 2032, growing from $822.4 million in 2022 at a CAGR of 6.4 % from 2023 to 2032.
Inhalation capsules' capacity to deliver medications directly to the lungs allows for quick and concentrated treatment of respiratory illnesses. This customized administration strategy minimizes systemic side effects while boosting therapeutic efficacy. Typically, capsules are designed to be used with specialized inhalation devices such as dry powder inhalers (DPIs) or metered-dose inhalers (MDIs). As the pharmaceutical industry continues to look for new and more effective ways to provide medication, inhalation capsules are emerging as a viable option.
One of the key reasons projected to drive the market growth is the exceptional efficacy of medicine delivery achieved by inhalation. The respiratory system offers a direct and efficient route to the circulation, allowing medication activity to begin immediately. This is particularly crucial for treating diseases characterized by severe aggravations, as quick relief is required. The lungs provide a huge surface area for drug absorption, and the thin alveolar membranes allow therapeutic chemicals to reach the bloodstream rapidly. As a result, inhalation capsules give a more rapid and direct pharmacological response than traditional oral delivery, allowing patients to experience quicker relief and better overall outcomes. The rapid onset of action increases the efficacy of inhalation capsules.
Stringent regulatory framework that oversees pharmaceutical products, particularly inhalation capsules is one of the major factors anticipated to hamper the market revenue growth. Regulatory authorities use strict criteria and processes to ensure that pharmaceuticals are safe, effective, and of high quality. Manufacturers need to stick to Good Manufacturing Practices (GMP), which requires maintaining complete control over every stage of the production process. Compliance with these regulations necessitates substantial investment in technology, equipment, and personnel training, which adds to the overall complexity of the production process. The intricate design and content of inhalation capsules contribute to their complexity. These capsules usually include specialized materials, such as polymers, that must meet stringent stability, compatibility, and biocompatibility criteria.
Inhalation capsules provide pharmaceutical firms a unique chance to reformulate current medications or introduce novel chemicals that can be successfully given via the respiratory route. Inhalation capsule has the potential to revitalize drug development pipelines by providing benefits such as a faster start of action, less systemic adverse effects, and better patient compliance. The pharmaceutical sector may capitalize on these prospects by investing in R&D to produce inhalable formulations for a variety of therapeutic areas, including respiratory disorders, systemic ailments, and even vaccinations. All these factors are anticipated to create several growth opportunities in the inhalation capsules market during the forecast period.
The key players profiled in this report include Capsugel, Qualicaps, ACG Worldwide, Cipla, Novartis, AstraZeneca plc, Chiesi Farmaceutici S.p.A., Elpen S.A., Vectura Group Plc, and Boehringer Ingelheim GmbH. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as diversification of product portfolios & mergers and acquisitions.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inhalation capsules market analysis from 2022 to 2032 to identify the prevailing inhalation capsules market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the inhalation capsules market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
Key Market Segments
By Type
By Application
By Region
Key Market Players:
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: INHALATION CAPSULES MARKET, BY TYPE
CHAPTER 5: INHALATION CAPSULES MARKET, BY APPLICATION
CHAPTER 6: INHALATION CAPSULES MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
- TABLE 01. GLOBAL INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 02. INHALATION CAPSULES MARKET FOR GELATIN CAPSULES, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. INHALATION CAPSULES MARKET FOR HYPROMELLOSE CAPSULES, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 05. INHALATION CAPSULES MARKET FOR ASTHMA TREATMENT, BY REGION, 2022-2032 ($MILLION)
- TABLE 06. INHALATION CAPSULES MARKET FOR COPD MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. INHALATION CAPSULES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. INHALATION CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. NORTH AMERICA INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 10. NORTH AMERICA INHALATION CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 11. NORTH AMERICA INHALATION CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 12. U.S. INHALATION CAPSULES MARKET, BY TYPE, 2022-2032 ($MILLION)
LIST OF FIGURES
